Alpha Tau Medical Ltd. (DRTS)

2.7100 -0.1200 (-4.24%) At close: 04:00PM EDT

Alpha Tau Medical Ltd.

Kiryat Hamada Street 5
Jerusalem 9777605
Israel
972 3 577 4115
https://www.alphatau.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 121

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Uzi Sofer	CEO & Chairman	630k	N/A	1970
Mr. Raphi Levy	Chief Financial Officer	424k	N/A	1985
Mr. Amnon Gat	Chief Operations Officer	340k	N/A	1975
Mr. Peter M. Melnyk	Chief Commercial Officer	376k	N/A	1962
Dr. Robert B. Den M.D.	Chief Medical Officer & Member of Scientific Advisory Board	401k	N/A	1979
Mr. Ronen Segal	Chief Technology Officer	380k	N/A	1973
Prof. Yona Keisari	Chief Scientific Officer & Member of Scientific Advisory board	N/A	N/A	1947
Ms. Rebecca Becker	Vice President of legal	N/A	N/A	N/A
Prof. Itzhak Kelson	Chief Physics Officer & Member of Scientific Advisory Board	N/A	N/A	1940
Ms. Yael Zeiger	Corporate Controller	N/A	N/A	1983

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Corporate governance

Alpha Tau Medical Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.